醫師介紹
醫師學術論文
Paper
薛博仁 Po-Ren Hsueh 檢驗醫學中心副院長
薛博仁醫師畢業於台灣大學學士後醫學系,現擔任中國醫藥大學附設醫院檢驗醫學中心副院長、檢驗醫學部部主任、內科部感染科主治醫師。專長於治療各種不明原因發燒、結核與非結核分枝桿菌感染、黴菌感染以及新興病毒感染等;在臨床微生物學、感染症、抗藥性機轉和監測與分子流行病學等領域也有豐富的研究經驗。
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | (Muh-Yong Yen)*、(Jonathan Schwartz)、薛博仁(Hsueh, Po-Ren),The implications of the COVID-19 pandemic for long term care facilities,CURRENT OPINION IN INFECTIOUS DISEASES,2022 Aug,35(4):370-377 | 2022 . 08 |
2 | 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、周家卉(Chia-Hui Chou)、何茂旺(Mao-Wang Ho)、劉于瑄(LIU YU-HSUAN)、林秀姍(Hsiu-Hsien Lin)、陳冠妃(Chen, Kuan-Fei)、薛博仁(Hsueh, Po-Ren)*,FilmArray Meningitis/Encephalitis (M/E) false-negative for cryptococcal meningitis,JOURNAL OF INFECTION,2022 Jul,85(1):90-122 | 2022 . 07 |
3 | (Mitsunori Yoshida)、(Jung-Yien Chien)、(Kozo Morimoto)、(Takeshi Kinjo)、(Akio Aono)、(Yoshiro Murase)、(Keiji Fujiwara)、(Yuta Morishige)、(Hiroaki Nagano)、(Ruwen Jou)、(Naoki Hasegawa)、(Manabu Ato)、(Yoshihiko Hoshino)、薛博仁(Hsueh, Po-Ren)*、(Satoshi Mitarai),Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan,Microbiology Spectrum,2022 Jun,10(3):e0057122 | 2022 . 06 |
4 | (Shio-Shin Jean)、(Wen-Chien Ko)、(Min-Chi Lu)、(Wen-Sen Lee)、薛博仁(Hsueh, Po-Ren)*、(SMART Program),Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020,Expert Review of Anti-Infective Therapy,2022 Jun,20(6):941-953 | 2022 . 06 |
5 | 曾宇銓(Yu-chuan Tseng)、林柏謙(Peter Bor-Chian Lin)、蕭瓊子(Chiung-Tzu Hsiao)、薛博仁(Hsueh, Po-Ren)*,Multiplex PCR rapid testing for meningitis/encephalitis,JOURNAL OF INFECTION,2022 Jun,84(6):834-872 | 2022 . 06 |
6 | 田霓(Ni Tien)、張煜昌(Yu-Chang Chang)、陳柏谷(PoKu Chen)、林惠茹(Hui-Ju Lin)、張詩欣(Shih-Hsin Chang)、藍忠亮(Joung-Liang Lan)、薛博仁(Hsueh, Po-Ren)、張敬昆、陳得源(Der-Yuan Chen)*,The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study,Biomedicines,2022 Apr,10(4):911 | 2022 . 04 |
7 | (Tsai-Wen Wan)、(Yu-Jung Liu)、(Yu-Ting Wang)、林瑜姿(Yu-Tzu Lin)、(Jia-Chuan Hsu)、(Jui-Chang Tsai)、(Hao-Chieh Chiu)、薛博仁(Hsueh, Po-Ren)、(Wei-Chun Hung)*、(Lee-Jene Teng)*,Potentially conjugative plasmids harboring Tn6636 , a multidrug-resistant and composite mobile element, in Staphylococcus aureus,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2022 Apr,55(2):225-233 | 2022 . 04 |
8 | (Yoshinori Yamano)*、(NaokiI shibashi)、(Miho Kuroiwa)、(Miki Takemura)、(Wang-Huei Sheng)、薛博仁(Hsueh, Po-Ren)*,Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan,Journal of Global Antimicrobial Resistance,2022 Mar,28():120-124 | 2022 . 03 |
9 | (Shio-Shin Jean)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019,INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2022 Mar,59(3):106521 | 2022 . 03 |
10 | (Wei-Yao Wang)、薛博仁(Hsueh, Po-Ren)、(Shih-Ming Tsao)*,Genotyping of methicillin-resistant Staphylococcus aureus isolates causing invasive infections using spa typing and their correlation with antimicrobial susceptibility,INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2022 Mar,59(3):106525 | 2022 . 03 |
11 | (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015–2019,ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2022 Feb,66(2): | 2022 . 02 |
12 | 林瑜姿(Yu-Tzu Lin)*、(Wei-Chun Hung)、(Tsai-Wen Wan)、(Hsin Li)、(Tai-Fen Lee)、薛博仁(Hsueh, Po-Ren)、(Lee-Jene Teng)*,Staphylococcus taiwanensis sp. nov., isolated from human blood,INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY,2022 Feb,72(2):005262 | 2022 . 02 |
13 | (Yu-Lin Lee)、(Hsien-Meng Chen)、(Ing-Moi Hii)、薛博仁(Hsueh, Po-Ren)*,Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment,INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2022 Feb,59(2):106528 | 2022 . 02 |
14 | (Ting-Kuang Yeh)、(Shio-Shin Jean)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、(Hsueh-Ju Lin)、(Po-Yu Liu)*、薛博仁(Hsueh, Po-Ren)*,Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy,INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2022 Jan,59(1): | 2022 . 01 |
15 | (Yu-Tsung Huang)、(Yao-Wen Kuo)、(Nan-Yao Lee)、田霓(Ni Tien)、(Chun-Hsing Liao)、(h Lee-Jene Teng)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Evaluating NG-Test CARBA 5 Multiplex immunochromatographic and Cepheid Xpert CARBA-R assays among carbapenem-Resistant Enterobacterales isolates associated with bloodstream infection,Microbiology Spectrum,2022 Jan,10(1):e01728-21 | 2022 . 01 |
16 | 薛博仁(Hsueh, Po-Ren),Clostridioides difficile infection: an emerging zoonosis?,Expert Review of Anti-Infective Therapy,2021 Dec,19(12):1543-1552 | 2021 . 12 |
17 | (Chen, Sharon C-A)*、(Perfect, John)、(Colombo, Arnaldo L.)、(Cornely, Oliver A.)、(Groll, Andreas H.)、(Seidel, Danila)、薛博仁(Hsueh, Po-Ren)、(Ip, Margaret)、(Munoz, Patricia),Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM,LANCET INFECTIOUS DISEASES,2021 Dec,21(12):375-386 | 2021 . 12 |
18 | (Meng-Lan Zhou)、(Zi-Ran Wang)、(Yan-Bing Li)、(Timothy Kudinha)、(Jian Wang)、(Yao Wang)、(Meng Xiao)、(Ying-Chun Xu)*、(Zheng-Yin Liu)*、薛博仁(Hsueh, Po-Ren)*,Rapid identification of Streptococcus pneumoniae serotypes by cpsB gene-based sequetyping combined with multiplex PCR,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Nov,S1684-1182(): | 2021 . 11 |
19 | (Chih-Cheng Lai)、(Chien-Ming Chao)、薛博仁(Hsueh, Po-Ren)*,Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Oct,54(5):767-775 | 2021 . 10 |
20 | (Shio-Shin Jean)、(Yu-Lin Lee)、(Po-Yu Liu)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Sep,3(21):00182-1-00182-1 | 2021 . 09 |
21 | (Chun-Hsing Liaoe)*、薛博仁(HSUEH PO-REN)*,Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam,Journal of Global Antimicrobial Resistance,2021 Sep,26():301-307 | 2021 . 09 |
22 | 薛博仁(Hsueh, Po-Ren)*、(Wen-Chien Ko)*,The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales,Antibiotics-Basel,2021 Sep,10(9):1086 | 2021 . 09 |
23 | (Chih-Cheng Lai)、(I-Tzu Chen)、(Chien-Ming Chao)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,COVID-19 vaccines: concerns beyond protective efficacy and safety,Expert Review of Vaccines,2021 Aug,20(8):1013-1025 | 2021 . 08 |
24 | 薛博仁(Hsueh, Po-Ren)*、(d Peck Toung Ooi)*,Animal Coronavirus Diseases: Parallels with COVID-19 in Humans,Viruses-Basel,2021 Aug,13(8):1507 | 2021 . 08 |
25 | (Po-Yu Liu)、(Wen-Chien Ko)、(Wen-Sen Lee)、(Po-Liang Lu)、(Yen-Hsu Chen)、(Shu-Hsing Cheng)、盧敏吉(Min-Chi Lu)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Pei-Lan Shao)、(Yu-Lin Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、薛博仁(Hsueh, Po-Ren)*,In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Aug,4(21):00186-00189 | 2021 . 08 |
26 | (Chih-Cheng Lai)、(Wen-Chien Ko)、(Chih-Jung Chen)、(Po-Yen Chen)、(Yhu-Chering Huang)、(Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)*,COVID-19 vaccines and thrombosis with thrombocytopenia syndrome,Expert Review of Vaccines,2021 Aug,20(8):1027-1035 | 2021 . 08 |
27 | 盧敏吉(Min-Chi Lu)、薛博仁(Hsueh, Po-Ren)*,National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020,Journal of Global Antimicrobial Resistance,2021 Aug,26():308-316 | 2021 . 08 |
28 | (Ying-Chun Xu)*、薛博仁(Hsueh, Po-Ren)*,Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review,Microorganisms,2021 Jul,9(7):1536 | 2021 . 07 |
29 | (Hsih-Yeh Tsai)、(Yu-Lin Lee)、(Po-Yu Liu)、盧敏吉(Min-Chi Lu)、(Pei-Lan Shao)、(Po-Liang Lu)、(Shu-Hsing Cheng)、(Wen-Chien Ko)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Wen-Sen Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Yen-Hsu Chen)、(Chun-Hsing Liao)、薛博仁(Hsueh, Po-Ren)*,Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART),INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2021 Jul,58(1):106353-106353 | 2021 . 07 |
30 | (Yu-Te Tsai)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Pei-Lan Shao)、(Po-Liang Lu)、(Shu-Hsing Cheng)、(Wen-Chien Ko)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Wen-Sen Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、(Chun-Yu Lin)、(Yen-Hsu Chen)*、薛博仁(Hsueh, Po-Ren)*,Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Jun,2021(21):00105-00105 | 2021 . 06 |
31 | (Chih-Cheng Lai)、(Chin-Te Lu)、(Kuo-Chin Kao)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Apr,54(2):182-184 | 2021 . 04 |
32 | 鄭心瑜(Hsin-Yu Cheng)、(Shio-Shin Jean)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、(Po-Yu Liu)、薛博仁(Hsueh, Po-Ren)*,Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review,Frontiers in Cellular and Infection Microbiology,2021 Apr,23(11):601968-601968 | 2021 . 04 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | ,社團法人台灣感染管制學會第二十九次會員大會暨學術研討會,高雄展覽館,2022.03.19~2022.03.20,COVID-19 快篩在國內外防疫與醫院感控之定位與應用 | 2022 . 03 |
2 | ,台灣微生物學會第二十三屆第三次會員大會暨學術研討會,南港展覽館一館402ab會議室,2021.12.5 ~2021.12.5 , | 2021 . 12 |
3 | ,台灣臨床病理暨檢驗醫學會110年學術研討會,南港展覽館一館402ab會議室,2021.12.4 ~2021.12.4 , | 2021 . 12 |
4 | ,2021台灣微生物學會學術研討會,台北南港展覽館一館,2021.12.4 ~2021.12.4 ,Staphylococcus taiwanensis: a new species? | 2021 . 12 |
5 | 跨部門導入Power BI監控平台降低全院血液培養汙染率,社團法人台灣醫事檢驗學會 110年度年會暨學術發表會,線上直播,2021.11.6 ~2021.11.7 , | 2021 . 11 |
6 | ,18th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI SINGAPORE 2021),Singapore (virtual),2021.11.11~2021.11.13,Treatment of XDR and PDR Gram negative bacteria | 2021 . 11 |
7 | 從自動確認系統Delta check發現罕見的虎克效應,台灣醫事檢驗學會110年度年會暨學術發表會,台北,2021.11.6 ~2021.11.6 , | 2021 . 11 |
8 | 打破傳統締造血液培養鑑定新趨勢,社團法人台灣醫事檢驗學會 110年度年會暨學術發表會,線上直播,2021.11.6 ~2021.11.7 , | 2021 . 11 |
9 | ,長照疫苗研討會(Hybrid)主題:新冠病毒疫情下、長期照顧機構疫苗接種新知,Webex 線上課程,2021.11.27~2021.11.27,腦膜炎疫苗 | 2021 . 11 |
10 | ,次世代定序檢測落地與癌症精準醫療研討會,張榮發國際會議中心 (直播會議),2021.10.8 ~2021.10.8 , | 2021 . 10 |
11 | ,13th International Symposium on Antimicrobial Agents and Resistance 2021 (ISAAR 2021),South Korea (Vitural),2021.09.9 ~2021.09.10,Epidemiology and impact of carbapenem-resistant Acinetobacter and Pseudomonas | 2021 . 09 |
12 | ,Laboratory Medicine Congress & Exhibition & KSLM 62nd Annual Meeting (LMCE 2021) Laboratory Medicine; Stepping Forward to the New Era,South Korea (virtual),2021.09.30~2021.10.2 ,COVID-19 laboratory diagnosis in Taiwan | 2021 . 09 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,MOST 111-2320-B-039-054,柯文謙、游家鑫(Jiaxin Yu),科技部,利用細菌鑑定質譜資料建置碳青黴烯酶類型人工智慧預測平台,2022.8.1~2023.7.31 | 2022 . 08 |
2 | 個別型,MOST 109-2314-B-039-060-MY2,簡榮彥、盛望徽、陳世英、柯文謙、李文生、李垣樟、陳彥旭、盧敏吉(Min-Chi Lu)、劉伯瑜、黃景泰、李允吉、廖俊星、黃建賢、黃俊凱、湯宏仁,科技部,評估次世代總體基因體定序(metagenomic next-generation sequencing)於微生物學困難診斷的敗血症病人之檢測效能及臨床應用,2021.8.1~2022.7.31 | 2021 . 08 |
3 | 個別型,MOST 109-2314-B-039-060-MY2,盛望徽、簡榮彥、陳世英、柯文謙、李文生、李垣樟、陳彥旭、盧敏吉(Min-Chi Lu)、劉伯瑜、黃景泰、李允吉、廖俊星、黃建賢、黃俊凱、湯宏仁,科技部,評估次世代總體基因體定序(metagenomic next-generation sequencing)於微生物學困難診斷的敗血症病人之檢測效能及臨床應用,2020.8.1~2021.7.31 | 2020 . 08 |
專利技術
暫無資料獲獎事蹟
獲獎/Award (獲獎名稱,給獎單位,獲獎日期) |
日期 | |
1 | Highly Cited Researcher 2021,Clarivate,2021.11.16 | 2021 . 11 |